Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1996-8-6
|
pubmed:abstractText |
Barbiturates have previously been demonstrated to reduce focal cerebral ischemic brain damage. However, the dose of drug required to elicit maximal neuroprotection has not been defined. The authors' hypothesized that doses of pentobarbital substantially lower than those required to cause electroencephalographic burst suppression would result in maximal magnitudes of reduction of cerebral infarct volume.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0003-3022
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1475-84
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8669689-Animals,
pubmed-meshheading:8669689-Brain,
pubmed-meshheading:8669689-Brain Ischemia,
pubmed-meshheading:8669689-Electroencephalography,
pubmed-meshheading:8669689-Glucose,
pubmed-meshheading:8669689-Male,
pubmed-meshheading:8669689-Neuroprotective Agents,
pubmed-meshheading:8669689-Pentobarbital,
pubmed-meshheading:8669689-Rats,
pubmed-meshheading:8669689-Rats, Wistar
|
pubmed:year |
1996
|
pubmed:articleTitle |
Electroencephalographic burst suppression is not required to elicit maximal neuroprotection from pentobarbital in a rat model of focal cerebral ischemia.
|
pubmed:affiliation |
Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA. warne002@mc.duke.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|